Document is current
Any future updates will be listed below
-
Authors
Geiger, Jessica Morlando https://orcid.org/0009-0002-1706-2382
Brady, Brenna L.
Lew, Carolyn R. https://orcid.org/0000-0003-1115-0672
Jennings, Mark
Mo, Chen
Van Brunt, Kate https://orcid.org/0009-0007-9738-8302
Dezube, Rebecca
-
Funding
Funding for this research was provided by:
Vertex Pharmaceuticals
- License Information
-
More Information
Article History
Received: 12 December 2025
Accepted: 25 February 2026
First Online: 18 March 2026
Declarations
:
: Jessica Morlando Geiger, Mark Jennings, Chen Mo, and Kate Van Brunt are employees of Vertex Pharmaceuticals Incorporated and may own stock or stock options in that company. Brenna L. Brady And Carolyn R. Lew are employees of Merative who received funding from Vertex to conduct this study. Rebecca Dezube reports consulting fees from Vertex Pharmaceuticals Incorporated.
: All database records are de-identified and fully compliant with United States patient confidentiality requirements, including the Health Insurance Portability and Accountability Act (HIPAA) of 1996. As all database records are de-identified and certified to be in compliance with the conditions set forth in Sects. 164.514 (a)-(b)1ii of the HIPAA privacy rule, this study was determined to be exempt from Institutional Review Board.
